Advanced Biomed Inc. Files Q4 2024 10-Q

Ticker: ADVB · Form: 10-Q · Filed: Apr 15, 2025 · CIK: 1941029

Advanced Biomed INC. 10-Q Filing Summary
FieldDetail
CompanyAdvanced Biomed INC. (ADVB)
Form Type10-Q
Filed DateApr 15, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: 10-Q, quarterly-report, financials

TL;DR

Advanced Biomed Inc. (BME) filed its 10-Q for Q4 2024 on 4/15/25. Check financials.

AI Summary

Advanced Biomed Inc. filed its 10-Q for the quarterly period ended December 31, 2024. The company, incorporated in Nevada and headquartered in Reno, operates in the medical laboratories sector. The filing was made on April 15, 2025, under SEC file number 001-42548.

Why It Matters

This filing provides investors with the latest financial performance and operational updates for Advanced Biomed Inc. for the fourth quarter of 2024.

Risk Assessment

Risk Level: low — This is a standard quarterly filing with no immediate red flags or significant new disclosures.

Key Players & Entities

FAQ

What is the primary business of Advanced Biomed Inc.?

Advanced Biomed Inc. operates in the SERVICES-MEDICAL LABORATORIES sector, with SIC code 8071.

When was the quarterly period covered by this 10-Q filing?

The quarterly period ended on December 31, 2024.

On what date was this 10-Q filed with the SEC?

This 10-Q was filed on April 15, 2025.

What is the SEC file number for Advanced Biomed Inc.?

The SEC file number for Advanced Biomed Inc. is 001-42548.

Where is Advanced Biomed Inc. incorporated?

Advanced Biomed Inc. is incorporated in Nevada.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on April 15, 2025 regarding Advanced Biomed Inc. (ADVB).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing